Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Fumai Paste helps heal skin damage from chemotherapy better than magnesium sulfate.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

Fludalanine failed as an effective oral antibiotic despite efforts.

Betulinic acid can help treat hepatitis C by stopping virus replication.

We need safe, affordable drugs to fight coronaviruses effectively.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Created finasteride complex to increase water solubility and drug release.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

TRPV1 is involved in pain, various body functions, and diseases, but targeting it for treatment is challenging.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Combining fluticasone propionate and UV-A is more effective for vitiligo than using either alone.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.